Exendin-4 (recombinant formulation)

exendin-4 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exendin-4 (recombinant formulation), covering 2017-06-26 to 2017-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects [Phase 1]

See pricing